USPTO serial 79317845
STRIKE PHARMA
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Feb 7, 2023
- Examiner
- HAN, DAWN L
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.
Need help with STRIKE PHARMA?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Donna J. Bunton
Donna J. Bunton NIXON & VANDERHYE P.C.901 NORTH GLEBE ROAD, 11TH FLOORARLINGTON, VA 22203UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 001 | Chemicals for use in industry for production of antibodies and synthetic and natural peptides | ACTIVE | — |
| 005 | Pharmaceutical preparations for human use for the treatment and prevention of diseases and conditions in the areas of immunology, oncology, immune-oncology, diabetes, autoimmunology, dermatology, gynecology, urology, gastroenterology and ophthalmology; veterinary preparations for the treatment and prevention of diseases and conditions in the areas of immunology, oncology, immune-oncology, diabetes, autoimmunology, dermatology, gynecology, urology, gastroenterology and ophthalmology; vaccines; therapeutic medicines for the treatment and prevention of diseases and conditions in the areas of immunology, oncology, immune-oncology, diabetes, autoimmunology, dermatology, gynecology, urology, gastroenterology and ophthalmology; pharmaceutical preparations for the treatment of diseases and conditions in the areas of immunology, oncology, immuno-oncology, diabetes, autoimmunology, dermatology, gynecology, urology, gastroenterology and ophthalmology; therapeutic antibodies for the treatment and prevention of diseases and conditions in the areas of immunology, oncology, immune-oncology, diabetes, autoimmunology, dermatology, gynecology, urology, gastroenterology and ophthalmology | ACTIVE | — |
| 010 | Delivery systems in the nature of implantable drug delivery ports for the deferred, controlled or immediate release of active substances of pharmaceutical preparations; inhalers for medical use; syringes for injection and medical purposes | ACTIVE | — |
| 042 | Research and development within the biological, pharmacological, veterinary, microbiological, biomedical, pharmabiotical, biotherapeutical and biotechnological areas; research and development of new products featuring a synthetic antibody library including methods for selection and screening of such; research and development in the area of personalized medicine; medical laboratory services related to production of antibodies; research and development in the area of antibodies | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Strike Pharma AB
- Other trademarks owned by Strike Pharma AB
- Other trademarks owned by Strike Pharma AB
- Other trademarks in Class 001
- Other trademarks in Class 005
- Other trademarks in Class 010
- Other trademarks in Class 042
- Similar marks named STRIKE PHARMA
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| May 30, 2023 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| May 8, 2023 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| May 8, 2023 | FIMP | FINAL DISPOSITION PROCESSED | — |
| May 7, 2023 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Feb 7, 2023 | NRCC | NOTICE OF REGISTRATION CONFIRMATION EMAILED | — |
| Feb 7, 2023 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Feb 6, 2023 | OPNX | NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB | — |
| Jan 18, 2023 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Jan 18, 2023 | OPNR | NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB | — |
| Nov 22, 2022 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Nov 22, 2022 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Nov 21, 2022 | GPNX | NOTIFICATION PROCESSED BY IB | — |
| Nov 11, 2022 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Nov 2, 2022 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Nov 2, 2022 | OP2R | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB | — |
| Nov 2, 2022 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Oct 17, 2022 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Jul 25, 2022 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Jul 25, 2022 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Jul 25, 2022 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Jul 25, 2022 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| May 31, 2022 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| May 31, 2022 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| May 31, 2022 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Apr 4, 2022 | RFNT | REFUSAL PROCESSED BY IB | — |
| Mar 17, 2022 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Mar 17, 2022 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Feb 17, 2022 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Feb 16, 2022 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Feb 7, 2022 | DOCK | ASSIGNED TO EXAMINER | — |
| Dec 11, 2021 | ADCH | CHANGE OF NAME/ADDRESS REC'D FROM IB | — |
| Aug 20, 2021 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Aug 16, 2021 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Aug 12, 2021 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |